Elsevier

Medical Hypotheses

Volume 36, Issue 1, September 1991, Pages 33-42
Medical Hypotheses

Does prolactin play a role in skin biology and pathology?

https://doi.org/10.1016/0306-9877(91)90161-QGet rights and content

Abstract

Despite its extensive repertoire of biological activities, which include the growth - and osmoregulation of epithelial tissues as well as immunoregulatory properties, the potential significance of the pituitary hormone prolactin (PRL) for human skin biology and pathology has yet to be fully appreciated. In this essay, the hypothesis is presented that PRL acts as a neuroendocrine modulator of skin epithelial cell proliferation and of the skin immune system by forming a ‘prolactin-circuit’ between the central nervous system and the skin. Binding to specific skin receptors, modulation of cytokine release in the skin, and stimulation of somatomedin release by mesenchymal cells are among the suggested pathways by which PRL could affect epithelial cell growth in the skin. Potential feedback signals, arising from the skin and modifying pituitary PRL release, are briefly outlined. Centering on the role of PRL in both psoriasis and hair growth as models for studying the proposed PRL-skin connection, clinical and experimental evidence in support of this theory is discussed in the context of a ‘neuroimmune-dermatological’ perspective.

References (107)

  • A.R. Buckley et al.

    Prolactin as a hepatotrophic hormone

  • R Palatsi et al.

    Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne

    Acta Derm Venereol (Stockh)

    (1986)
  • J.M. Ebertz et al.

    Substance P-induced histamine release in human cutaneous mast cells

    J Invest Dermatol

    (1987)
  • D.H. Russell et al.

    Prolactin receptor on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine

    J Immunol

    (1985)
  • J.E. Blalock

    A molecular basis for bidirectional communication between the immune and neuroendocrine systems

    Physiol Rev

    (1989)
  • M.C. Hadley

    Endocrinology

    M.C. Hadley

    Endocrinology

    M.C. Hadley

    Endocrinology

    M.C. Hadley

    Endocrinology

    M.C. Hadley

    Endocrinology

    M.C. Hadley

    Endocrinology

    M.C. Hadley

    Endocrinology

  • F.J. Ebling et al.

    Hormones and hair growth

  • T.J. McKenna et al.

    Prolactin in hirsute women

    Acta Endocrinol

    (1984)
  • C.E. Feingold et al.

    Endocrine-skin interactions (I)

    J Am Acad Dematol

    (1987)
  • C.E. Feingold et al.

    Endocrine-skin interactions (II)

    J Am Acad Dermatol

    (1988)
  • F. Drago

    The role of prolactin in rat grooming behavior

    Ann NY Acad Sci

    (1988)
  • S.F. Gilbert
  • R.P.C. Shiu et al.

    Biological actions of prolactin in human breast cancer

    Rec Prog in Hormone Res

    (1987)
  • H Matzkin et al.

    The role of increased prolactin levels under GnRH analogue treatment in advanced prostatic carcinoma

    Cancer

    (1988)
  • T Kadar et al.

    Receptors for prolactin, somatostatin and luteinizing hormone-releasing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormone-releasing hormone and somatostatin

  • A. Golander et al.

    Prolactin synthesis by human chorion-decidual tissue: a possible source of prolactin in the amniotic fluid

    Science

    (1978)
  • A. Golander et al.

    Decidual prolactin (PRL)-releasing factor stimulates the synthesis of PRL from human decidual cells

    Endocrinology

    (1988)
  • J. Chapitis et al.

    Observation of production of immunoactive prolactin by normal human connective tissue in cell culture

    In vitro

    (1989)
  • G.E. DiMattia et al.

    A human B-lymphoblastoid cell line produces prolactin

    Endocrinology

    (1988)
  • P.C. Hiestand et al.

    Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine

  • D.W. Montgomery et al.

    Concanavalin A-stimulated murine splenocytes produce a factor with prolactin-like bioactivity and immunoreactivity

    Biochem Biophys Res Commun

    (1987)
  • E Nagy et al.

    Immunomodulation by bromocriptine

    Immunopharmacology

    (1983)
  • E Nagy et al.

    Regulation of immunity in rats by lactogenic and growth homones

    Acta Endocrinol

    (1983)
  • R Gerli et al.

    Reduced number of natural killer cells in patients with pathological hyperprolactinemia

    Clin Exp Immunol

    (1986)
  • A Vidaller et al.

    T-cell dysregulation in patients with hyperprolactinemia: effect of bromocriptine treatment

    Clin Immunol Immunopathol

    (1986)
  • B.L. Spangelo et al.

    Stimulation of in vivo antibody production and concanavalin A-induced mouse spleen cell mitogenesis by prolactin

    Immunopharmacology

    (1987)
  • E.W. Bernton et al.

    Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice

    Science

    (1987)
  • D.H. Russell et al.

    Neonatal administration of prolactin antiserum alters the developmental pattern of T- and B-lymphocytes in the thymus and spleen of BALBc female mice

  • J.D. Bos et al.

    The skin immune system

    Immunol Today

    (1986)
  • V.B. Morhenn

    Keratinocyte proliferation in wound healing and skin diseases

    Immunology Today

    (1988)
  • B.J. Nickoloff

    Role of interferon-gamma in cutaneous trafficking of lymphocytes with emphasis on molecular and cellular adhesion events

    Arch Dermatol

    (1988)
  • A.J. Smith et al.

    Effects of melatonin implantation on spermatogenesis, the molting cycle and plasma concentrations of melatonin. LH, prolactin and testosterone in male blue fox (Alapex lagopins)

    J Reprod Fertil

    (1987)
  • I. Blum et al.

    Increased hair loss as the side-effect of bromocriptine treatment

    N Engl J Med

    (1980)
  • P Fritsch

    Dermatologie

  • P Serafini et al.

    Prolactin modulates peripheral androgen metabolism

    Fertil Steril

    (1986)
  • J.I. Harper et al.

    Dermatological aspects of the use of cyclosporine A for prophylaxis of graft-versus-host disease

    Br J Dermatol

    (1984)
  • Cited by (41)

    • Clinical efficacy of propylthiouracil and its influence on prolactin in psoriatic patients

      2011, Clinical Biochemistry
      Citation Excerpt :

      An elevated level of PRL was observed in both male and female psoriatic patients. Our result is in accordance with previous findings [13,15,38,39]. PTU treatment decreased the level of PRL significantly in a duration dependent manner.

    • Prolactin: An emerging force along the cutaneous-endocrine axis

      2010, Trends in Endocrinology and Metabolism
      Citation Excerpt :

      These effects are evident in women with hyperprolactinemia, who develop hirsutism and seborrhea, not uncommonly associated with female pattern balding [13]. Patients treated with hyperprolactinemia-inducing neuroleptic agents also develop seborrhea [9], but the mechanism of PRL-induced seborrhea remains unclear. As sebocytes are prominent target cells of neuroendocrine signaling [61], PRL might also contribute to the aggravating effect of psychoemotional stress on acne vulgaris.

    • Prolactin and the skin: A dermatological perspective on an ancient pleiotropic peptide hormone

      2009, Journal of Investigative Dermatology
      Citation Excerpt :

      For example, PRL's prominent role in lower vertebrate skin osmoregulation and its putative function in the regulation of human sweat gland activities raise the question of whether PRL is also important in hyperhidrosis, another condition greatly influenced by psychoemotional stress. The psoriasis-promoting effects of PRL summarized above have also invited the speculation that PRL is part of the elusive systemic factor that underlies the Koebner phenomenon in psoriasis (Paus, 1991). The pilosebaceous unit harbors many additional pointers to the “PRL–skin connection.”

    View all citing articles on Scopus
    View full text